Article
Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer
19 May 2016
Abstract excerpt
Aptamers provide a potential source of alternative targeting molecules for existing antibody diagnostics and therapeutics. In this work, we selected novel DNA aptamers targeting the HER2 receptor by an adherent whole-cell SELEX approach. Individual aptamers were identified by next generation sequencing and bioinformatics analysis. Two aptamers, HeA2_1 and HeA2_3, were shown to bind the HER2 protein with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
